
Moving beyond the binary: how the convergence of small and large molecules is reshaping pharmaceutical R&D
<a href="https://news.google.com/rss/articles/CBMi2AFBVV95cUxQeGUxRGxXN0J6bXpZOHk3SUFRSFRVOUF5OUxqaDB6MS03YVRaZ2E5T3BpSjdtYjNMY2l5YnpORVljLUU5RU5jUEpoT3pqeC1nNlJxckxDVXI0c0RjWDJPb2x1eUpxMTAtRjJ2OXlPcTBRckZoOUVEbVdZREtoY3B3RTl1bUQtcVBobUw4ajVoU1U4WmxsMTVlVUJWNy1CbGxVeXFXSlg1Y2lZQU5ZMV9BcElSWEdYbVRCVVh5TVJVS2RCYWVpRVc3R3RYRDhRc3QyMVZ1cjROMlM?oc=5" target="_blank">Moving beyond the binary: how the convergence of small and large molecules is reshaping pharmaceutical R&D</a>&nbsp;&nbsp;<font color="#6f6f6f">Drug Discovery & Development</font>

